Integral Molecular In response to the COVID-19 pandemic, AboundBio developed potent neutralizing monoclonal antibodies (MAbs) against SARS-CoV-2.
Questions? Call: 215-966-6061
Integral Molecular In response to the COVID-19 pandemic, AboundBio developed potent neutralizing monoclonal antibodies (MAbs) against SARS-CoV-2.
Join Our Mailing List